Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice

NCT00782314 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00782314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00782314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
April 30, 2009
Enrollment
400 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

asthma